Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with Stage II to IIIB non-small cell lung cancer (a specific type and stage of lung cancer)
- People whose lung cancer has tested negative for two specific genetic markers called EGFR and ALK
- People who are willing to participate, sign a consent form, follow the study requirements, and attend follow-up appointments
Who may not be able to join:
- People who have had another type of cancer at any point in the past 5 years
- People who have an autoimmune disease (a condition where the immune system attacks the body's own tissues), as this may make a key type of treatment used in the trial unsuitable for them (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18017321551
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between HRD and MPR rate/2 years DFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.